Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Gerich

Showing results (61-70 of 241) with videos related to

Pageof 25
Sort By:
The New England Journal of Medicine|July 25, 1985
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitusP E Cryer, J E Gerich
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesityP J Campbell, J E Gerich
Clinical Pharmacology and Therapeutics|October 1, 1987
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitusF P Kennedy, J E Gerich
Advances in Internal Medicine|January 1, 1988
Mechanisms for prevention, development, and reversal of hypoglycemiaP J Campbell, J E Gerich
Diabetes/Metabolism Reviews|March 1, 1988
Overview of counterregulation and its abnormalities in diabetes mellitus and other conditionsJ E Gerich, P J Campbell
Lancet (London, England)|June 9, 1973
Glucagon secretion in obesityJ E Gerich, M Langlois, C Noacco
Diabetes|September 1, 1980
Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell functionM Itoh, L Mandarino, J E Gerich
Endocrinology|March 1, 1975
Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretionJ E Gerich, R Lovinger, G M Grodsky
Diabetes|April 1, 1971
Clinical and metabolic characteristics of hyperosmolar nonketotic comaJ E Gerich, M M Martin, L Recant
Diabetes|May 20, 1999
Role of the human kidney in glucose counterregulationC Meyer, J M Dostou, J E Gerich
Pageof 25

Showing results (61-70 of 241) with videos related to

Sort By:
Pageof 25
The New England Journal of Medicine|July 25, 1985
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitusP E Cryer, J E Gerich
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesityP J Campbell, J E Gerich
Clinical Pharmacology and Therapeutics|October 1, 1987
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitusF P Kennedy, J E Gerich
Advances in Internal Medicine|January 1, 1988
Mechanisms for prevention, development, and reversal of hypoglycemiaP J Campbell, J E Gerich
Diabetes/Metabolism Reviews|March 1, 1988
Overview of counterregulation and its abnormalities in diabetes mellitus and other conditionsJ E Gerich, P J Campbell
Lancet (London, England)|June 9, 1973
Glucagon secretion in obesityJ E Gerich, M Langlois, C Noacco
Diabetes|September 1, 1980
Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro: evidence for a physiologic role for endogenous somatostatin in the regulation of pancreatic A- and B-cell functionM Itoh, L Mandarino, J E Gerich
Endocrinology|March 1, 1975
Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretionJ E Gerich, R Lovinger, G M Grodsky
Diabetes|April 1, 1971
Clinical and metabolic characteristics of hyperosmolar nonketotic comaJ E Gerich, M M Martin, L Recant
Diabetes|May 20, 1999
Role of the human kidney in glucose counterregulationC Meyer, J M Dostou, J E Gerich
Pageof 25